CANTAI THERAPEUTICS, INC.
Profile
Company Names
CANTAI THERAPEUTICS, INC.
Addresses
3675 MARKET STREET, SUITE 200, PHILADELPIA, PA 19104
Phone Numbers
603-996-1218
Entity Type:
CORPORATION
Industry:
BIOTECHNOLOGY
Year Incorporated:
2023
State Incorporated:
DELAWARE
Total Amount Raised:
$4,250,000.00
Number of Funding Rounds:
3
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
3
2026-01-15
$3,000,000.00
$3,000,000.00
$0.00
Equity
2
2025-07-02
$550,000.00
$1,100,000.00
$550,000.00
Equity
1
2023-11-06
$700,000.00
$3,000,000.00
$2,300,000.00
Equity
People
First Name
Middle Name
Last Name
Titles
Related Companies
ERRIK
ANDERSON
EXECUTIVE OFFICER, DIRECTOR
AVITIDE, INC.
| KAIROS BIOLOGICS FOUNDATION LLC
| GREEN D FOUNDERS FUND 2014-I, LLLP
| COMPASS THERAPEUTICS LLC
| GTP AW FUND II, LLC
| UDH MSPV I LLC
| UDH MSPV II LLC
| VERNAL BIOSCIENCES, INC.
| WHEELER BIO, INC.
| MYTIDE THERAPEUTICS, INC.
| CANTAI THERAPEUTICS, INC.
| ALUMNI VENTURES GROUP LLC
| AAKHA BIOLOGICS, INC.
| ANGIEX, INC.
| 82VS SEED FUND, LP
ERRIK
B.
ANDERSON
EXECUTIVE OFFICER
GEETA
VEMURI
EXECUTIVE OFFICER, DIRECTOR
ARGINETIX, INC.
| CEMPRA HOLDINGS, LLC
| CORRIDOR PHARMACEUTICALS, INC.
| GLIKNIK INC
| SYNTIMMUNE, INC.
| ONCORESPONSE INC
| AGENT CAPITAL FUND I LP
| PYXIS ONCOLOGY, INC.
| AGENT CAPITAL FUND II, LP
| VITTORIA BIOTHERAPEUTICS, INC.
| CARBON BIOSCIENCES, INC.
| CANTAI THERAPEUTICS, INC.
| AGENT CAPITAL FUND III LP
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
